Liposomes as MR contrast agents: pros and cons

Area of Science:

• Nanomedicine
• Biophysics
• Medical Imaging

Background:

• Liposomes are widely used for drug delivery and imaging.
• Traditional MRI contrast agents encapsulated within liposomes face limitations due to water flux across the lipid bilayer.
• Existing strategies to enhance water exchange or membrane permeability have drawbacks like reduced stability.

Purpose of the Study:

• To develop novel MRI contrast agents that overcome the limitations of conventional liposome-encapsulated agents.
• To investigate manganese complexes incorporated into the liposome bilayer for improved contrast enhancement.
• To evaluate the efficacy of these novel agents for liver metastasis detection.

Main Methods:

• Design and synthesis of novel manganese complexes with ligands attached to dual acyl chains for liposome bilayer incorporation.
• Measurement of R1 and R2 relaxivity values for the novel manganese complexes.
• Assessment of liver metastasis detection in a rat model using the developed manganese-based liposomal agents at low doses.

Main Results:

• Achieved R1 and R2 values exceeding 20/mmol sec-1, over five times higher than Gd-DTPA.
• Demonstrated significantly improved detection of hepatic metastases in rats at manganese doses as low as 10 μmol/kg.
• Confirmed membrane-bound manganese complexes as highly effective liver imaging agents.

Conclusions:

• Incorporating manganese complexes into liposome bilayers is a viable strategy to create highly effective MRI contrast agents.
• These novel agents exhibit superior relaxivity and enhanced liver metastasis detection compared to existing agents.
• Further development and human clinical trials are warranted for these promising liver imaging agents.